The development of chimeric antigen receptor T cells has provided hope for patients with hematologic malignancies, but their commercial use has been limited to an option of last resort. Research has intensified to maximize the effectiveness of CAR T-cell therapy, reduce toxicity and expand its use to other cancers, all while clinicians become more familiar […]

Digital therapeutics company DarioHealth is teaming up with MediOrbis to launch a new virtual care initiative for diabetes patients. Eligible Medicare members who have diabetes can receive virtual care to help manage their conditions, including telehealth delivered by MediOrbis and remote patient monitoring through DarioHealth’s artificial-intelligence-powered digital chronic care platform under their existing Medicare benefit, the companies […]

DarioHealth (NSDQ:DRIO) announced that it launched a new virtual care initiative with MediOrbis to improve virtual care for diabetes. New York-based DarioHealth’s collaboration with MediOrbis is slated to offer eligible Medicare members with diabetes a convenient method for virtual care that includes MediOrbis’ telehealth offerings and DarioHealth’s AI-powered remote patient monitoring, according to a news […]